Home
Conditions
Leukemia, Myeloid

Clinical trial condition

Leukemia, Myeloid

Explore clinical trials studying Leukemia, Myeloid. Study availability and eligibility vary by location and protocol.

3,104 public trials 618 recruiting studies

Refine in advanced search Browse all conditions

Leukemia, Myeloid trial results

Completed

Bone Marrow and Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer

NCT00004232

Conditions: Amyloidosis, Blast Crisis, Blood Coagulation Disorders, +87 more
Locations: Robert H. Lurie Comprehensive Cancer Center, Northwestern University Chicago, Illinois, United States

View Trial Details

Completed

Treosulfan and Fludarabine in Treating Younger Patients Who Are Undergoing a Donor Stem Cell Transplant for Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or Myelodysplastic Syndrome

NCT00253513

Conditions: Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +12 more
Locations: OHSU Knight Cancer Institute Portland, Oregon, United States

Seattle Cancer Care Alliance Seattle, Washington, United States

Fred Hutchinson Cancer Research Center Seattle, Washington, United States

View Trial Details

Completed

Arsenic Trioxide and Imatinib Mesylate in Treating Patients With Chronic Myelogenous Leukemia

NCT00053248

Conditions: Bone Marrow Diseases, Chronic Disease, Disease Attributes, +11 more
Locations: UCLA Department of Medicine, Division of Hematology/Oncology Los Angeles, California, United States

H. Lee Moffitt Cancer Center Tampa, Florida, United States

OHSU Knight Cancer Institute Portland, Oregon, United States

View Trial Details

Completed

Cellular Therapy With Cord Blood Cells

NCT00427557

Conditions: Blood Protein Disorders, Bone Marrow Diseases, Cardiovascular Diseases, +30 more
Locations: UT MD Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

Busulfan and Fludarabine in Patients With AML and MDS

NCT00502905

Conditions: Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +6 more
Locations: U.T.M.D. Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

Doxorubicin Hydrochloride Liposome and Bortezomib in Treating Patients With Refractory Hematologic Cancer or Malignant Solid Tumor or Metastatic Breast Cancer

NCT00237627

Conditions: Adnexal Diseases, Blast Crisis, Blood Protein Disorders, +99 more
Locations: Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill Chapel Hill, North Carolina, United States

View Trial Details

Completed

Chemotherapy in Treating Patients Who Have Hematologic Cancer

NCT00004047

Conditions: Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +29 more
Locations: University of Texas - MD Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

Paclitaxel in Treating Patients With Refractory or Recurrent Acute Leukemia or Chronic Myelogenous Leukemia

NCT00003230

Conditions: Blast Crisis, Bone Marrow Diseases, Carcinogenesis, +21 more
Locations: Kantonspital Aarau Aarau, Switzerland

Office of Walter Weber-Stadelman Basel, Switzerland

University Hospital Basel, Switzerland

Inselspital, Bern Bern, Switzerland

View Trial Details

Completed

A Phase 1/2 Study of SB1518 for the Treatment of Advanced Myeloid Malignancies

NCT00719836

Conditions: Acute Myelogenous Leukemia, Bone Marrow Diseases, Chronic Disease, +19 more
Locations: The University of Chicago Hospitals Chicago, Illinois, United States

MD Anderson Cancer Center Houston, Texas, United States

Fred Hutchinson Cancer Center Seattle, Washington, United States

View Trial Details

Completed

Study of Clofarabine & Cytosine Arabinoside Therapy for Older Adults With Acute Myeloid Leukemia

NCT00081822

Conditions: Acute Myeloid Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
Locations: University of Alabama at Birmingham Birmingham, Alabama, United States

The University of Nebraska Omaha, Nebraska, United States

The Cleveland Clinic Foundation Cleveland, Ohio, United States

View Trial Details

Leukemia, Myeloid

Leukemia, Myeloid trial results

Related conditions